DMIIR — Drugs Made In America Acquisition II Corp.

Nasdaq · Financials · Diversified Financial Services · CIK 2040475 ·
Last close
Market Cap
52W High
52W Low
ADV30
Next earnings
Drugs Made In America Acquisition II Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. It intends to source and evaluate companies focused on the pharmaceutical sector. Drugs Made In America Acquisition II Corp. was incorporated in 2024 and is based in New York, New York.
No quarterly fundamentals indexed for this ticker.

Peers — same industry

TickerNameMarket CapLastDaily %
HASI HA Sustainable Infrastructure Capital, Inc. $5.27B $41.21
DMII Drugs Made In America Acquisition II Corp. $641.46M $10.07
INV Innventure, Inc. $536.21M $6.38
BCSS Bain Capital GSS Investment Corp. $478.38M $10.20
EVAC EQV Ventures Acquisition Corp. II $477.46M $10.17

News headlines (Yahoo Finance, 1h cache)

NexGen Energy’s Rook I Project Emerges as a Key Source in the Next Uranium Supply Wave
2026-02-24 21:42 · Yahoo
Drugs Made In America Acquisition II Corp. (NASDAQ:DMII) is largely controlled by institutional shareholders who own 79% of the company
2025-12-04 15:05 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.